Mental Health Consequences of COVID-19 ID'd Across Populations
TUESDAY, Jan. 5, 2021 -- Short-term mental health consequences of COVID-19 are equally high across affected countries and across gender, according to a review published in the January issue of Psychiatry Research.
Jude Mary Cénat, Ph.D., from the University of Ottawa in Ontario, Canada, and colleagues conducted a systematic review and meta-analysis of 55 peer-reviewed studies with 189,159 participants to examine the prevalence of depression, anxiety, insomnia, posttraumatic stress disorder (PTSD), and psychological distress related to COVID-19. The proportion of individuals with symptoms of these conditions was generated, and between-group differences were examined for gender, health care workers, and regions where studies were conducted.
The researchers found that the prevalence of depression, anxiety, insomnia, PTSD, and psychological distress was 15.97, 15.15, 23.87, 21.94, and 13.29 percent, respectively. The only between-group difference was a higher prevalence of insomnia among health care workers than others.
"This study shows that regardless of gender, group, or region, the current pandemic is impacting the mental health of affected populations," the authors write. "This study provides initial evidence for the implementation of mental health prevention and intervention programs that provide holistic care to affected individuals."
© 2021 HealthDay. All rights reserved.
Posted: January 2021
Further Support and Information on COVID-19
Read this next
FRIDAY, Jan. 22, 2021 -- Treatment with bamlanivimab and etesevimab, but not monotherapy with bamlanivimab, is associated with a reduction in severe acute respiratory syndrome...
FRIDAY, Jan. 22, 2021 -- There was a decrease in the total number of pediatric emergency department visits in 2020, but the proportion of trauma-related visits increased,...
THURSDAY, Jan. 21, 2021 -- Patient age is associated with the choice of telepsychiatry visit type, and many patients report being likely to continue with telepsychiatry even after...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.